| |
| |
|
| Insider
Information: |
Zambrowicz Brian P |
| Relationship: |
EVP, Chief Scientific ... |
| City: |
The Woodlands |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
278,703 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$440,351 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
278,703 |
|
|
| Total
Value |
$440,351 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lexicon Pharmaceuticals Inc |
LXRX |
EVP, Chief Scientific ... |
2014-02-28 |
278,703 |
2005-08-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Chief Scientific Officer |
• • – |
2014-02-28 |
4 |
D |
$1.92 |
$34,917 |
D/D |
(18,186) |
278,703 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Chief Scientific Officer |
• • – |
2014-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,750 |
296,889 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Chief Scientific Officer |
• • – |
2013-02-28 |
4 |
D |
$1.98 |
$23,150 |
D/D |
(11,692) |
234,139 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Chief Scientific Officer |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
42,750 |
245,831 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Chief Scientific Officer |
• • – |
2013-01-31 |
4 |
D |
$2.11 |
$28,483 |
D/D |
(13,499) |
203,081 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Chief Scientific Officer |
• • – |
2013-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
42,100 |
216,580 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Chief Scientific Officer |
• – – |
2011-02-23 |
4 |
D |
$1.81 |
$14,265 |
D/D |
(7,881) |
158,851 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Chief Scientific Officer |
• – – |
2011-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
26,243 |
166,732 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Chief Scientific Officer |
• – – |
2010-02-12 |
4 |
D |
$1.91 |
$17,211 |
D/D |
(9,011) |
140,489 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Chief Scientific Officer |
• – – |
2009-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
55,200 |
156,800 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Research |
• – – |
2007-02-01 |
4 |
S |
$3.89 |
$203,447 |
D/D |
(52,300) |
101,600 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Research |
• – – |
2007-02-01 |
4 |
OE |
$1.67 |
$150,300 |
D/D |
90,000 |
153,900 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Research |
• – – |
2005-08-15 |
4 |
S |
$4.60 |
$144,029 |
D/D |
(31,100) |
63,900 |
|
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Research |
• – – |
2005-08-15 |
4 |
OE |
$0.22 |
$20,900 |
D/D |
95,000 |
95,000 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
